NCT00486356 2024-01-03
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
University of Nebraska
Phase 1 Completed
University of Nebraska
Fox Chase Cancer Center
UNC Lineberger Comprehensive Cancer Center
British Columbia Cancer Agency
Yale University
Duke University
British Columbia Cancer Agency